Monograph Details
|
|
Infections & Infestations
> Bacterial infections
|
|
SUMYCIN ORAL SUSP |
| Manufacturer |
|
Par Pharmaceutical, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Tetracycline antibiotic. |
| Generic Name |
|
Tetracycline 125mg/5mL; fruit flavor; contains sulfites. |
| Also |
|
• SUMYCIN
|
| Indications |
|
Tetracycline-sensitive infections, including those caused by rickettsiae and Mycoplasma pneumoniae; also cholera, psittacosis, plague, shigellosis. |
| Children |
|
<8 yrs: not recommended. Take 1 hour before or 2 hours after meals. ≥8 yrs: 25–50 mg/kg/day divided into 2–4 doses. |
| Adults |
|
Take 1 hour before or 2 hours after meals. 250–500mg 4 times daily. |
| Precautions |
|
Renal impairment. Asthma (susp). Monitor blood, renal, and hepatic function in long-term use. Sun or UV light. Continue therapy for 2 days after symptoms improve. Pregnancy, nursing mothers: not recommended. |
| Interactions |
|
Avoid methoxyflurane, photosensitizing agents. May antagonize bactericidal antibiotics. May increase serum digoxin levels. Reduced absorption with antacids, iron, zinc, calcium, magnesium, dairy products, urinary alkalinizers, other multivalent cations. May reduce effectiveness of oral contraceptives. Monitor prothrombin time with oral anticoagulants. |
| Adverse Reactions |
|
Photosensitivity, GI upset, rash, blood dyscrasias, increased BUN, hepatotoxicity. |
| How Supplied |
250mg—100, 1000
500mg—100, 500
Susp—pt |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
